Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds
Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal
Pain Relievers Protect Against Breast Cancer
Proteomics Promises Ways To Track Response To Therapy
Study Sheds Light On How NSAIDS Prevent Colon Cancer
Hypothyroidism Associated With Reduced Breast Cancer
Statin Drugs May Prevent Breast Cancer, Lab Suggests
Leptin Could Be Indicator Of Breast Cancer Risk
Tumor Cells In Blood May Indicate Aggressive Cancer
Brain Gliomas Progress When Gene Function Is Lost
Stem Cell Transplant More Effective than Chemotherapy
FDA Approves HPV Test
Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
